The European Society of Cardiology (ESC) has launched four guidelines at the 2017 ESC Congress:
- 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation; this updated guidance aligns with other ESC guidelines, including the focused update on dual antiplatelet therapy (DAPT)
- 2017 ESC/EACTS guidelines for the management of valvular heart disease; this guideline focuses on the management of acquired valvular heart disease (endocarditis or congenital valve disease—including pulmonary valve disease—are covered by other ESC guidelines)
- 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases; ‘peripheral’ arterial disease in these guidelines refers to arterial disease that is non-aortic and non-coronary. The guideline covers atherosclerotic disease in a wide range of peripheral arteries.
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease; this guideline aims to address the optimal use of DAPT in patients with established coronary artery disease.
The ESC works to disseminate evidence-based scientific knowledge to professionals involved in treating cardiovascular disease to improve outcomes for their patients, focusing on the advancement of prevention, diagnosis, and management in diseases of the heart and blood vessels.